Re: Pathologic Response and Surgical Outcomes in Patients Undergoing Nephrectomy Following Receipt of Immune Checkpoint Inhibitors for Renal Cell Carcinoma

Eur Urol. 2020 Aug;78(2):288. doi: 10.1016/j.eururo.2020.04.002. Epub 2020 Apr 27.

Authors

Zine-Eddine Khene¹, Géraldine Pignot², Karim Bensalah³

Affiliations

¹ Department of Urology, University of Rennes, Rennes, France.
² Department of Surgical Oncology, Institut Paoli-Calmette, Marseille, France.
³ Department of Urology, University of Rennes, Rennes, France. Electronic address: karim.bensalah@chu-rennes.fr.

PMID: 32349930
DOI: 10.1016/j.eururo.2020.04.002

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Renal Cell* / drug therapy
Humans
Immune Checkpoint Inhibitors
Kidney Neoplasms* / surgery
Nephrectomy
Treatment Outcome

Substances

Immune Checkpoint Inhibitors